Inovio Presents Accelerated FDA Approval of VOCERYQ
Inovio presents accelerated FDA approval of VOCERYQ for adults with RRP.
Related stories
China Central Bank Intervenes Again to Stem Stock Market Declines
China's central bank intervened again on Monday to stem declines in the country's stock market. The iShares MSCI China A ETF, which tracks domestically listed companies, is down 14
M impact | REGULATION | Nov 02, 2026, 03:07 PM UTC
Lupin Wins FDA Approval for Amifampridine Tablets
The FDA approved Lupin’s 10 mg amifampridine tablets, bioequivalent to Firdapse. Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivit
M impact | REGULATION | Nov 02, 2026, 02:47 PM UTC
Belgian Government in Crisis After Budget Talks Collapse
Belgium’s prime minister offers resignation after budget talks collapse.
M impact | REGULATION | Nov 02, 2026, 02:45 PM UTC
Inovio shares surge 186% after FDA approves rare-disease treatment
Inovio Pharmaceuticals shares surged 186% after the FDA approved a treatment for a rare respiratory condition.
H impact | REGULATION | Nov 02, 2026, 02:45 PM UTC
India Supreme Court Dismisses Government Challenge to Vedanta Arbitration Awards
The Supreme Court dismissed the Union government’s challenge to a Delhi High Court order allowing Vedanta and Ravva Oil (Singapore) to enforce foreign arbitration awards involving
M impact | REGULATION | Nov 02, 2026, 02:36 PM UTC
China Rolls Out Measures to Support Struggling Stocks
China rolled out support measures to aid struggling stocks. The alert says the PBOC conducted swaps but is truncated before further details.
M impact | REGULATION | Nov 02, 2026, 02:36 PM UTC